Clearance studies during subsequent sessions of double filtration plasmapheresis

Artificial Organs

Volumn 30, Issue 2, 2006, Pages 111-114

  Yeh, Jiann Horng ^a,b   Chen, Wei Hung ^a,c   Chiu, Hou Chang ^a,b   Bai, Chyi Huey ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Clearance; Double filtration plasmapheresis; Molecular weight; Plasma half life

Indexed keywords

CHOLESTEROL; LIPOPROTEINS; PATIENT MONITORING;

CLEARANCE; CLEARANCE RATES; DOUBLE FILTRATION PLASMAPHERESIS; FURTHER TREATMENTS; HALF LIVES; HIGH SLOPES; LIPOPROTEIN CHOLESTEROL; PLASMA HALF-LIFE; SERUM PROTEINS; STANDARD PROTOCOLS;

PATIENT TREATMENT;

ALBUMIN; CHOLESTEROL; GLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEIN; PLASMA PROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; BIOFILTRATION; CLEARANCE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOLOGY; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PLASMAPHERESIS; PRIORITY JOURNAL; SERUM;

EID: 33645002093     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2006.00189.x     Document Type: Conference Paper

References (19)

1. Koo AP Overview of therapeutic apheresis in the USA Ther Apher 1999 3 4 7
2. The Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment of plasmapheresis Neurology 1996 47 840 3
3. Goodnough LT Brecher ME Kanter MH et al. Transfusion medicine. Part I: blood transfusion N Engl J Med 1999 340 438 47
4. Mokrzycki MH Kaplan AA Therapeutic plasma exchange: complications manage Am J Kidney Dis 1994 23 817 27
5. Sutton DC Nair RC Rock G and the Canadian Apheresis Study Group. Complications of plasma exchange Transfusion 1989 29 124 7
6. Rossi PL Cecchini L Minichella G et al. Comparison of the side effects of therapeutic cytapheresis and those of other types of hemapheresis Hematologica 1991 76 S75 80
7. McLeod BC Sniecinski I Ciavarella D et al. Frequency of immediate adverse effects associated with therapeutic apheresis Transfusion 1999 39 282 8
8. Agishi T Kaneko I Hasuo Y et al. Double filtration plasmapheresis Trans Am Soc Artif Intern Organs 1980 26 406 9
9. Yeh JH Chiu HC Double filtration plasmapheresis in myasthenia gravis - analysis of clinical efficacy and prognostic parameters Acta Neurol Scand 1999 100 305 9
10. Yeh JH Chiu HC Comparison between double filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis J Neurol 2000 247 510 3
11. Yeh JH Chen WH Chiu HC The hemodynamic effects of the different vascular accesses used for double-filtration plasmapheresis J Clin Apheresis 2001 16 125 9
12. Yeh JH Chen WH Chiu HC Complications of double-filtration plasmapheresis Transfusion 2004 44 1621 5
13. Chirnside A Urbaniak SJ Prowse CV Keller AJ Coagulation abnormalities following intensive plasma exchange on the cell separator Brit J Haematol 1981 48 627 34
14. Keller AJ Chirnside A Urbaniak SJ Coagulation abnormalities produced by plasma exchange on the cell separator with special reference to fibrinogen and platelet level Br J Haematol 1979 42 593 603
15. Yeh JH Chiu HC Plasmapheresis in myasthenia gravis - comparative study of daily versus alternately daily schedule Acta Neurol Scand 1999 99 147 51
16. Lin SM Yeh JH Lee CC Chiu HC Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis J Clin Apheresis 2003 18 67 70
17. Rapaport SI Introduction to Hematology 2nd Edition Philadelphia J. B. Lippincott Co 1987
18. Yeh JH Chiu HC Optimal volume of processed plasma and total number of selective plasmapheresis sessions in the treatment of patients with severe generalized myasthenia gravis J Clin Apheresis 1999 14 177 80
19. Yeh JH Lee MF Chiu HC Plasmapheresis for severe lipemia - comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants J Clin Apheresis 2003 18 32 6